Statistical evaluation of influence of xanthan gum and guar gum blends on dipyridamole release from floating matrix tablets

Drug Development and Industrial Pharmacy

Volumn 33, Issue 3, 2007, Pages 327-334

  Patel, Viral F ^a   Patel, Natavarlal M ^a  

^a Shri B M Shah College of Pharmacy Modasa   (India)

Author keywords

Dipyridamole; Factorial design; Guar gum; Xanthan gum

Indexed keywords

DIPYRIDAMOLE; GUAR GUM; POLYMER; UNCLASSIFIED DRUG; XANTHAN; XANTURAL;

ANALYSIS OF VARIANCE; ARTICLE; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; FACTORIAL DESIGN; IN VITRO STUDY; MULTIPLE REGRESSION; STATISTICAL SIGNIFICANCE; TABLET FORMULATION;

ANALYSIS OF VARIANCE; DIFFUSION; DIPYRIDAMOLE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FACTOR ANALYSIS, STATISTICAL; GALACTANS; MANNANS; PLANT GUMS; POLYSACCHARIDES, BACTERIAL; TABLETS; VASODILATOR AGENTS;

EID: 34247467447     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601050155     Document Type: Article

References (27)

1. Altaf, S. A., Yu, K., Parasrampuria, J., & Friend, D. R. (1998). Guar gum based sustained release diltiazem. Pharm. Res., 15, 1196-1201.
2. Billa, N., & Yuen, K. H. (2000). Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS Pharma. Sci. Tech., 1, 1-8.
3. Bravo, S. A., Lamas, M. C., & Salomon, C. J. (2002). In vitro studies of diclofenac sodium controlled release from biopolymeric hydrophilic matrices. J. Pharm. Pharm. Sci., 5, 213-219.
4. Colombo, P., Bettini, R., Massimo, G., Cattellani, P. L., Santi, P., & Peppas, N.A. (1995). Drug diffusion front movement is important in drug release control from swellable matrix tablets. J. Pharm. Sci., 84, 991-997.
5. Cox, P. J., Khan, K. A., Munday, D. L., & Sujja-areevath, J. (1999). Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics. Int. J. Pharm., 193, 73-84.
6. Davis, S. S. (2005). Formulation strategies for absorption windows. Drug Dis. Today, 10, 249-257.
7. Derendorf, H., VanderMaelen, C. P., Brickl, R., MacGregor, T. R., & Eisert, W. (2005). Dipyridamole bioavailability in subjects with reduced gastric acidity. J. Clin. Pharmacol., 45, 845-850.
8. Durig, T., & Fassihi, R. (2002). Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. J. Control. Release, 80, 45-56.
9. Gu, C., Rao, D., Gandhi, R. B., Hilden, J., & Raghavan, K. (2005). Using a novel multi compartment dissolution system to predict the effect of the gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J. Pharm. Sci., 94, 199-208.
10. He, X., Kadomura, S., Takekuma, Y., Sugawara, M., & Miyazaki. K. (2004). A new system for the prediction of drug absorption using a pH controlled Caco-2 model: Evaluation of pH dependant soluble drug absorption and pH related changes in absorption. J. Pharm. Sci., 93, 71-77.
11. Kohri, N., Miyata, N., Takechi, S., & Nomura, A. (1992). Evaluation of pH independent sustained release granules of dipyridamole by using gastric acidity controlled rabbits and human subjects. Int. J. Pharm., 81, 49-58.
12. Korsmeyer, R. W., Gunny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983). Mechanism of potassium chloride release from compressed hydrophilic polymeric matrices: Effect of entrapped air. J. Pharm. Sci., 72, 1189-1191.
13. Kostewicz, E. S., Wunderlich, M., Brauns, U., Becker, R., Bock, T., & Dressman, J. B. (2004). Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J. Pharm. Pharmacol., 56, 43-51.
14. Krishnaiah, Y. S. R., Karthikeyan, R. S., Sankar, V. G., & Satyanarayana, V. (2002). Three layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J. Control. Release., 81, 45-56.
15. Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., & Hogan, J. E. (1993). The influence of concentration on the release of drugs from gels and matrices containing Methocel® . Int J Pharm., 100, 155-163.
16. Munday, D. L., & Cox, P. J. (2000). Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms. Int. J. Pharm., 203, 179-192.
17. Patel, V. F., & Patel, N. M. (2006). Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation. AAPS Pharm. Sci. Tech., 7, Article 17, E1-E7.
18. Reynolds, T. D., Gehrke, S. H., Hussain, A. S., & Shenouda, L. S. (1998). Polymer erosion and drug release characterization of HPMC matrices. J. Pharm. Sci., 87, 1115-1123.
19. Soppimath, K. S., Kulkarni, A. R., & Aminabhavi, T. M. (2001). Development of hollow microsphere as floating controlled release systems for cardiovascular drugs: Preparation and release characteristics. Drug Dev. Ind. Pharm., 27, 507-515.
20. Sugawara, M., Kadomura, S., He, X., Takekuma, Y., Kohri, N., & Miyazaki, K. (2005). The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH independent controlled release formulations. Euro. J. Pharm. Sci., 26, 1-8.
21. Sujja-areevath, J., Munday, D. L., Cox, P. J., & Khan, K. A. (1998). Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. Eur. J. Pharm. Sci., 6, 207-217.
22. Talukdar, M. M., Vanden, M. G., Augustijns, P., Tjandra, M. T., Verbeke, N., & Kinget, R. (1998). In vitro evaluation of xanthan gum as a potential excipient for oral controlled release matrix tablet formulation. Int. J. Pharm., 169, 105-113.
23. Talukdar, M.M., & Plaizier-Vercammen, J. (1993). Evaluation of xanthan gum as a hydrophillic matrix for controlled release dosage forms. Drug Dev. Ind. Pharm., 19, 1037-1046.
24. Vendruscolo, C. W., Andreazza, I. F., Ganter, J. L. M. S., Ferrero, C., & Bresolin, T. M. B. (2005). Xanthan and galactomannan (from Mimosa scabrella) matrix tablets for oral controlled delivery of theophylline. Int. J. Pharm., 296, 1-11.
25. Xu, G., & Sunada, H. (1995). Influence of formulation change on drug release kinetics from hydroxypropyl methylcellulose matrix tablets. Chem. Pharm. Bull., 43, 483-487.
26. Yeole, P. G., Khan, S., & Patel, V. F. (2005). Floating drug delivery systems: Need and development. Indian J. Pharm. Sci., 67, 265-272.
27. Zhou, R., Moench, P., Heran, C., Lu, X., Mathias, N., Faria, T. N., Wall, D. A., Hussain, M. A., Smith, R. L., & Sun, D. (2005). pH dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model. Pharm. Res., 22, 188-192.